Skrastins, I’s team published research in Khimiya Geterotsiklicheskikh Soedinenii in 1987-09-30 | 112-63-0

Khimiya Geterotsiklicheskikh Soedinenii published new progress about Bromination. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Category: esters-buliding-blocks.

Skrastins, I.; Kastrons, V.; Duburs, G.; Mazeika, I.; Kadis, V. published the artcile< Preparation of furo- and difuro-1,4-dihydropyridines via bromination of 2,6-dimethyl-3,5-bis(methoxycarbonyl)-4-(o-nitrophenyl)-1,4-dihydropyridines>, Category: esters-buliding-blocks, the main research area is furopyridine dihydro; difuropyridine dihydro; pyridine furo difuro.

Furo- and difuro-1,4-dihydropyridines I and II were prepared by bromination of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-nitrophenyl)-1,4-dihydropyridine with mild brominating agents, e.g., pyridine hydrogen tribromide, dioxane dibromide and NBS, followed by oxidation with 3N HNO3.

Khimiya Geterotsiklicheskikh Soedinenii published new progress about Bromination. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Category: esters-buliding-blocks.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Robichaud, Joeel’s team published research in Bioorganic & Medicinal Chemistry Letters in 2007-06-01 | 112-63-0

Bioorganic & Medicinal Chemistry Letters published new progress about Bone resorption. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Robichaud, Joeel; Bayly, Christopher I.; Black, W. Cameron; Desmarais, Sylvie; Leger, Serge; Masse, Frederic; McKay, Daniel J.; Oballa, Renata M.; Paquet, Julie; Percival, M. David; Truchon, Jean-Francois; Wesolowski, Gregg; Crane, Sheldon N. published the artcile< β-Substituted cyclohexanecarboxamide cathepsin K inhibitors: Modification of the 1,2-disubstituted aromatic core>, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is cyclohexanecarboxamide preparation cathepsin K inhibitor SAR.

Further SAR study around the central 1,2-disubstituted Ph of the previously disclosed Cat K inhibitor (-)-1 (I) has demonstrated that the solvent exposed P2-P3 linker can be replaced by various 5- or 6-membered heteroaromatic rings. While some potency loss was observed in the 6-membered heteroaromatic series (IC50 = 1 nM for pyridine-linked 4 vs 0.5 nM for phenyl-linked (±)-1), several inhibitors showed a significantly decreased shift in the bone resorption functional assay (10-fold for pyridine 4 vs 53-fold for (-)-1). Though this shift was not reduced in the 5-membered heteroaromatic series, potency against Cat K was significantly improved for thiazole 9 (IC50 = 0.2 nM) as was the pharmacokinetic profile of N-Me pyrazole 10 over our lead compound (-)-1.

Bioorganic & Medicinal Chemistry Letters published new progress about Bone resorption. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Kim, Moonsik’s team published research in Anticancer Research in 2022-01-31 | 112-63-0

Anticancer Research published new progress about Age groups. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application In Synthesis of 112-63-0.

Kim, Moonsik; Yoo, Jihwan; Chang, Jong Hee; Kim, Se Hoon published the artcile< Association of MGMT gene promoter methylation with clinicopathological parameters in patients with wild-type IDH glioblastoma>, Application In Synthesis of 112-63-0, the main research area is isocitrate dehydrogenase MGMT gene promoter methylation clinicopathol glioblastoma human; ATRX loss; MGMT; glioblastoma; hypermethylation; low methylation; methylation status; temozolomide chemotherapy; wild-type IDH.

The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) promoter plays a key role in response to temozolomide chemotherapy and disease prognosis in patients with wild-type isocitrate dehydrogenase (IDH) glioblastoma (GBM). The MGMT promoter methylation status and its association with clinicopathol. parameters were retrospectively analyzed in a cohort of 316 patients with GBM with wild-type IDH. MGMT methylation was significantly associated with ATRX chromatin remodeler (ATRX) loss and completion of the standard Stupp protocol. The median durations of overall and progression-free survival for the unmethylated, low-methylated (10-39%), and hypermethylated (≥40%) groups were 15, 23, and 30 mo and 11, 18, and 21 mo, resp. However, the improvement in the survival of the hypermethylated group was not statistically significant. We suggest a possible association between MGMT methylation status and ATRX mutations in GBM with wild-type IDH.

Anticancer Research published new progress about Age groups. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application In Synthesis of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Cioffi, Christopher L’s team published research in Journal of Medicinal Chemistry in 2019-06-13 | 112-63-0

Journal of Medicinal Chemistry published new progress about Complement Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application of C19H34O2.

Cioffi, Christopher L.; Racz, Boglarka; Varadi, Andras; Freeman, Emily E.; Conlon, Michael P.; Chen, Ping; Zhu, Lei; Kitchen, Douglas B.; Barnes, Keith D.; Martin, William H.; Pearson, Paul G.; Johnson, Graham; Blaner, William S.; Petrukhin, Konstantin published the artcile< Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis>, Application of C19H34O2, the main research area is RBP4 antagonist preparation hepatic steatosis.

Retinol-binding protein 4 (RBP4) serves as a transporter for all-trans-retinol (1) in the blood, and it has been proposed to act as an adipokine. Elevated plasma levels of the protein have been linked to diabetes, obesity, cardiovascular diseases, and nonalcoholic fatty liver disease (NAFLD). Recently, adipocyte-specific overexpression of RBP4 was reported to cause hepatic steatosis in mice. We previously identified an orally bioavailable RBP4 antagonist that significantly lowered RBP4 serum levels in Abca4-/- knockout mice with concomitant normalization of complement system protein expression and reduction of bisretinoid formation within the retinal pigment epithelium. We describe herein the discovery of novel RBP4 antagonists 48 and 59, which reduce serum RBP4 levels by >80% in mice upon acute oral dosing. Furthermore, 59 demonstrated efficacy in the transgenic adi-hRBP4 murine model of hepatic steatosis, suggesting that RBP4 antagonists may also have therapeutic utility for the treatment of NAFLD.

Journal of Medicinal Chemistry published new progress about Complement Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application of C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Miranda, Renata Rank’s team published research in Nanotoxicology in 2022 | 112-63-0

Nanotoxicology published new progress about BEN domain-containing protein 3 Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application In Synthesis of 112-63-0.

Miranda, Renata Rank; Oliveira, Anny Carolline Silva; Skytte, Lilian; Rasmussen, Kaare Lund; Kjeldsen, Frank published the artcile< Proteome-wide analysis reveals molecular pathways affected by AgNP in a ROS-dependent manner>, Application In Synthesis of 112-63-0, the main research area is proteome ROS bend3 NRF2 cytotoxicity; N-Acetyl L-cysteine; Silver nanoparticles; metal uptake; oxidative stress; proteomics.

The use of mass spectrometry-based proteomics has been increasingly applied in nanomaterials risk assessments as it provides a proteome-wide overview of the mol. disturbances induced by its exposure. Here, we used this technique to gain detailed mol. insights into the role of ROS as an effector of AgNP toxicity, by incubating Bend3 cells with AgNP in the absence or presence of an antioxidant N-acetyl L-cystein (NAC). ROS generation is a key player in AgNP-induced toxicity, as cellular homeostasis was kept in the presence of NAC. By integrating MS/MS data with bioinformatics tools, in the absence of NAC, we were able to pinpoint precisely which biol. pathways were affected by AgNP. Cells respond to AgNP-induced ROS generation by increasing their antioxidant pool, via NRF2 pathway activation. Addnl., cell proliferation-related pathways were strongly inhibited in a ROS-dependent manner. These findings reveal important aspects of the AgNP mechanism of action at the protein level.

Nanotoxicology published new progress about BEN domain-containing protein 3 Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application In Synthesis of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Yu, Jin-Sheng’s team published research in Chemistry – A European Journal in 2018 | 112-63-0

Chemistry – A European Journal published new progress about Alkaloids Role: CAT (Catalyst Use), USES (Uses). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Yu, Jin-Sheng; Noda, Hidetoshi; Shibasaki, Masakatsu published the artcile< Exploiting β-amino acid enolates in direct catalytic diastereo- and enantioselective C-C bond-forming reactions>, SDS of cas: 112-63-0, the main research area is hybrid dipeptide synthesis spiro compound Shibasaki catalyst alkaloid; isoxazolidinone synthon beta amino acid enolate synthesis solvent effect; enantioselective diastereoselective catalytic synthesis Mannich adduct coupling amino ketoacid; amino acids; asymmetric catalysis; organocatalysis; peptides; spiro compounds.

In contrast to the widespread use of α-amino acid-equivalent enolates for the preparation of non-natural amino acids, the utilization of β-amino-acid counterparts has been limited. This deficit has resulted in a short supply of β2, 2-amino acids bearing two substituents at the α-carbon, especially for peptide synthesis. Herein, racemic 4-substituted isoxazolidin-5-ones were used as precursors of β2-amino acid enolates in the direct catalytic diastereo- and enantioselective C-C bond-forming reactions, constructing two adjacent stereocenters in a highly stereoselective fashion. The obtained adducts were smoothly coupled with α-amino acid-derived α-ketoacids to afford α/β2, 2-hybrid dipeptides suitable for 9-fluorenylmethoxycarbonyl (Fmoc)-based solid-phase peptide synthesis (Fmoc = 9-fluorenylmethoxycarbonyl). Moreover, the Mannich adducts obtained from isatin-derived imines were converted to spirocyclic β-lactams, which have recently received increased attention due to their unique biol. activities and conformational preferences.

Chemistry – A European Journal published new progress about Alkaloids Role: CAT (Catalyst Use), USES (Uses). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Yang, Guo-Hui’s team published research in ACS Catalysis in 2020-02-07 | 112-63-0

ACS Catalysis published new progress about Alkylation catalysts (chiral sulfonamides). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application In Synthesis of 112-63-0.

Yang, Guo-Hui; Zheng, Hanliang; Li, Xin; Cheng, Jin-Pei published the artcile< Asymmetric Synthesis of Axially Chiral Phosphamides via Atroposelective N-Allylic Alkylation>, Application In Synthesis of 112-63-0, the main research area is atroposelective allylic alkylation MBH carbonate phosphamide; axially chiral phosphamide preparation crystal structure; mol structure axially chiral phosphamide; linear free energy relationship axially chiral phosphamide.

Axially chiral anilide compounds are an emerging but scarcely studied class of stereogenic mols. with potential applications as biol. active scaffolds. Because of the lower rotation barriers, the synthesis of these compounds is a challenging task. Also, the status of the limited structure type of chiral anilide constrains the latent capacity of the C-N axis as a chiral source in the application of asym. synthesis. Herein, the authors disclose an efficient protocol for the construction of the rationally designed axially chiral phosphamides via atroposelective N-allylic alkylation reaction of MBH carbonates and phosphamides. The simple hydroquinidine catalyst proves to be most efficient in this artroposelective strategy, delivering the desired axially chiral phosphamides in good yields and high enantioselectivities. A phosphamide compound, which contains both P-stereogenic center and C-N axial chirality, can be obtained by this method through a kinetic resolution process. Because of the large steric diaryl phosphoryl group, the synthesized axially chiral anilide has a large rotational barrier. As a demonstration, current studied axially chiral ortho-I substituted phosphamides could act as efficient chiral hypervalent I(III) catalysts for the asym. oxidative dearomatization of phenols. Also, a speculative model, which can explain the enantiocontrol, is proposed based on the exptl. observation and theor. calculation

ACS Catalysis published new progress about Alkylation catalysts (chiral sulfonamides). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application In Synthesis of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Yokota, Chisato’s team published research in Cancer Immunology Immunotherapy in 2022-01-31 | 112-63-0

Cancer Immunology Immunotherapy published new progress about Cancer immunotherapy. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, HPLC of Formula: 112-63-0.

Yokota, Chisato; Kagawa, Naoki; Takano, Koji; Chiba, Yasuyoshi; Kinoshita, Manabu; Kijima, Noriyuki; Oji, Yusuke; Oka, Yoshihiro; Sugiyama, Haruo; Tsuboi, Akihiro; Izumoto, Shuichi; Kishima, Haruhiko; Hashimoto, Naoya published the artcile< Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy>, HPLC of Formula: 112-63-0, the main research area is CD4 CD8 WT1 malignant glioma peptide vaccine immunotherapy; Cancer vaccine; Glioma; Immunotherapy; Intra-tumor immune response; Wilms tumor gene 1.

We have previously revealed the overexpression of Wilms’ tumor gene 1 (WT1) in malignant glioma and developed WT1 peptide vaccine cancer immunotherapy. A phase II clin. trial indicated the clin. efficacy of the WT1 peptide vaccine for recurrent malignant glioma. Here, we aimed to investigate the immunol. microenvironment in glioma tissues before and after WT1 peptide vaccine treatment. Paired tissue samples were obtained from 20 malignant glioma patients who had received the WT1 peptide vaccine for > 3 mo and experienced tumor progression, confirmed radiog. and/or clin., during vaccination. We discovered that the expression of WT1 and HLA class I antigens in the tumor cells significantly decreased after vaccination. Maintenance of WT1 expression, which is the target mol. of immunotherapy, in tumor cells during the vaccination period was significantly associated with a longer progression-free and overall survival. A high expression of HLA class I antigens and low CD4+/CD8+ tumor-infiltrating lymphocytes (TIL) ratio in pre-vaccination specimens, were also associated with a good prognosis. No statistically significant difference existed in the number of infiltrating CD3+ or CD8+ T cells between the pre- and post-vaccination specimens, whereas the number of infiltrating CD4+ T cells significantly decreased in the post-vaccination specimens. This study provides insight into the mechanisms of intra-tumoral immune reaction/escape during WT1 peptide vaccine treatment and suggests potential clin. strategies for cancer immunotherapy.

Cancer Immunology Immunotherapy published new progress about Cancer immunotherapy. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, HPLC of Formula: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Liu, Yue’s team published research in Advanced Synthesis & Catalysis in 2021-04-17 | 112-63-0

Advanced Synthesis & Catalysis published new progress about [3+2] Cycloaddition reaction catalysts (stereoselective). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, HPLC of Formula: 112-63-0.

Liu, Yue; Zhang, Ying; Huang, Qian-Wei; Gou, Chuan; Li, Qing-Zhu; Dai, Qing-Song; Leng, Hai-Jun; Li, Jun-Long published the artcile< Organocatalytic Enantioselective Synthesis of Tetrahydro-Furanyl Spirooxindoles via [3+2] Annulations of 3-Hydroxyoxindoles and Cyclic Ketolactams>, HPLC of Formula: 112-63-0, the main research area is hydoxyindole pyrrolidinedione cinchona catalyst enantioselective antitumor cyclization; tetrahydrofuranyl spirooxindole preparation.

Asym. construction of pharmacol. interesting tetrahydrofuranyl spirooxindole frameworks was achieved through organocatalytic [3+2] annulations of the readily available 3-hydroxyoxindoles and pyrrolidone-derived cyclic ketolactams. A variety of chiral spiro tetrahydrofuranyl products, which contained four contiguous stereocenters including two tetrasubstituted carbon centers were rapidly synthesized with remarkable results (up to 99% yield, >95:5 dr and 99:1 er). Synthetic derivatization of the hemiketal moiety enabled the installation of various halogen atoms into the structurally complex mols. in a stereospecific manner. Preliminary screening of anticancer bioactivity was performed, and 4 w showed obvious inhibitory capacity to the proliferation on a panel of cancer cell lines.

Advanced Synthesis & Catalysis published new progress about [3+2] Cycloaddition reaction catalysts (stereoselective). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, HPLC of Formula: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Novotny, Jan’s team published research in Physical Chemistry Chemical Physics in 2014 | 112-63-0

Physical Chemistry Chemical Physics published new progress about Density functional theory. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Reference of 112-63-0.

Novotny, Jan; Yurenko, Yevgen P.; Kulhanek, Petr; Marek, Radek published the artcile< Tailoring the properties of quadruplex nucleobases for biological and nanomaterial applications>, Reference of 112-63-0, the main research area is guanine quadruplex xanthine derivative mol dynamic simulation.

Guanine DNA quadruplexes are interesting and important biol. objects because they represent potential targets for regulatory drugs. Their use as building blocks for biomaterial applications is also being investigated. This contribution reports the in silico design of artificial building blocks derived from xanthine. Methods of quantum chem. were used to evaluate the properties of xanthine structures relative to those containing guanine, the natural reference used. Tailoring the xanthine core showed that the base stacking and the ion coordination were significantly enhanced in the designed systems, while the ion-transport properties were not affected. Our study suggests that the 9-deaza-8-haloxanthine bases (where the halogen is fluorine or chlorine) are highly promising candidates for the development of artificial quadruplexes and quadruplex-active ligands.

Physical Chemistry Chemical Physics published new progress about Density functional theory. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Reference of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics